ABT Molecular Imaging Inc:医療機器:M&Aディール及び事業提携情報

◆英語タイトル:ABT Molecular Imaging Inc - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C10319
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ABT Molecular Imaging Inc (ABT) is a medical imaging company engaged in the development of biomarker generator systems and related accessories. Its technology platform BG-75, a biomarker generator produces unit doses of molecular imaging drugs for positron emission tomography (PET) at the point of use, eliminating the need for chemistry and physics expertise. ABT ‘s generator includes a self-shielded mini-cyclotron for producing the positron emitting F-18 isotopes and microchemistry system for labeling specific molecules. The company markets its products through a network of sales and service distributors across the US, Europe, the Middle East, and Africa. ABT is headquartered in Louisville, Tennessee, the US.

ABT Molecular Imaging Inc – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ABT Molecular Imaging Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
ABT Molecular Imaging Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
ABT Molecular Imaging Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
ABT Molecular Imaging Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
ABT Molecular Imaging Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
ABT Molecular Imaging Inc, Medical Equipment, Deal Details 10
Venture Financing 10
ABT Molecular Raises USD10 Million in Venture Financing 10
ABT Molecular Imaging Raises USD0.7 Million in Venture Financing 11
ABT Molecular Imaging Raises USD0.78 Million in Venture Financing 12
ABT Molecular Imaging Raises USD0.8 Million in Venture Financing 13
ABT Molecular Imaging Raises US$0.5 Million In Venture Financing 14
ABT Molecular Imaging Secures USD1 Million in Venture Funding from Mountain Group Capital 15
ABT Molecular Imaging Raises US$6 Million In Series C Financing 16
ABT Molecular Imaging Raises US$0.2 Million In Venture Financing 17
ABT Molecular Imaging Raises US$0.5 Million In Venture Financing 18
Acquisition 19
Best ABT to Acquire ABT Molecular Imaging 19
ABT Molecular Imaging Inc – Key Competitors 20
ABT Molecular Imaging Inc – Key Employees 21
ABT Molecular Imaging Inc – Locations And Subsidiaries 22
Head Office 22
Appendix 23
Methodology 23
About GlobalData 23
Contact Us 23
Disclaimer 23

List of Tables
ABT Molecular Imaging Inc, Medical Equipment, Key Facts 2
ABT Molecular Imaging Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
ABT Molecular Imaging Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
ABT Molecular Imaging Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
ABT Molecular Imaging Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
ABT Molecular Imaging Inc, Deals By Market, 2012 to YTD 2018 8
ABT Molecular Imaging Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
ABT Molecular Raises USD10 Million in Venture Financing 10
ABT Molecular Imaging Raises USD0.7 Million in Venture Financing 11
ABT Molecular Imaging Raises USD0.78 Million in Venture Financing 12
ABT Molecular Imaging Raises USD0.8 Million in Venture Financing 13
ABT Molecular Imaging Raises US$0.5 Million In Venture Financing 14
ABT Molecular Imaging Secures USD1 Million in Venture Funding from Mountain Group Capital 15
ABT Molecular Imaging Raises US$6 Million In Series C Financing 16
ABT Molecular Imaging Raises US$0.2 Million In Venture Financing 17
ABT Molecular Imaging Raises US$0.5 Million In Venture Financing 18
Best ABT to Acquire ABT Molecular Imaging 19
ABT Molecular Imaging Inc, Key Competitors 20
ABT Molecular Imaging Inc, Key Employees 21

List of Figures
ABT Molecular Imaging Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
ABT Molecular Imaging Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
ABT Molecular Imaging Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
ABT Molecular Imaging Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
ABT Molecular Imaging Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
ABT Molecular Imaging Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
ABT Molecular Imaging Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
ABT Molecular Imaging Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[ABT Molecular Imaging Inc:医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • EndoChoice Inc:医療機器:M&Aディール及び事業提携情報
    Summary EndoChoice Inc (EndoChoice), a subsidiary of Boston Scientific Corp is a medical device company that develops and commercializes medical devices, diagnostic equipment, infection control products and endoscopic imaging systems. The company’s infection control products comprise biopsy valves, …
  • Biovista Inc-製薬・医療分野:企業M&A・提携分析
    Summary Biovista Inc (Biovista) is a drug development company that provides COSS platform technology support in uncovering non-obvious correlations between drugs. The company’s products are used for the treatment of neurodegenerative diseases, epilepsy, oncology and orphan diseases. It offers servic …
  • Unimedic AB:製薬・医療:M&Aディール及び事業提携情報
    Summary Unimedic AB (Unimedic), formerly Ergobe Pharma AB, a subsidiary of MedCap AB, is a pharmaceutical company which develops, manufactures, distributes and markets pharmaceutical products. The company offers non-licensed, extemporaneous, and licensed pharmaceuticals targeting the therapy areas w …
  • Revance Therapeutics Inc (RVNC):製薬・医療:M&Aディール及び事業提携情報
    Summary Revance Therapeutics Inc (Revance Therapeutics) develops, manufactures and commercializes novel botulinum toxin products. The company’s product candidate includes RT002, an injectable formulation of botulinum toxin type for the treatment of glabellar lines, cervical dystonia, and plantar fas …
  • SAE Towers Holdings LLC:企業の戦略的SWOT分析
    SAE Towers Holdings LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Cipla Ltd (CIPLA):企業の財務・戦略的SWOT分析
    Cipla Ltd (CIPLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Honkarakenne Oyj (HONBS):企業の財務・戦略的SWOT分析
    Honkarakenne Oyj (HONBS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Power Grid Corporation of India Ltd (POWERGRID EQ):企業の財務・戦略的SWOT分析
    Power Grid Corporation of India Ltd (POWERGRID EQ) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Revance Therapeutics Inc (RVNC):企業の財務・戦略的SWOT分析
    Revance Therapeutics Inc (RVNC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Shikoku Electric Power Co Inc:発電所・企業SWOT分析
    Shikoku Electric Power Co Inc - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key …
  • WorleyParsons Ltd (WOR):企業の財務・戦略的SWOT分析
    WorleyParsons Ltd (WOR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Scholastic Corporation:企業の戦略・SWOT・財務分析
    Scholastic Corporation - Strategy, SWOT and Corporate Finance Report Summary Scholastic Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Morneau Shepell Inc.:企業の戦略・SWOT・財務情報
    Morneau Shepell Inc. - Strategy, SWOT and Corporate Finance Report Summary Morneau Shepell Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • TriMas Corporation:企業のM&A・事業提携・投資動向
    TriMas Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's TriMas Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Cinkarna Celje d.d. Celje (CICG):企業の財務・戦略的SWOT分析
    Cinkarna Celje d.d. Celje (CICG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Grupa Lotos SA (LTS):企業の財務・戦略的SWOT分析
    Grupa Lotos SA (LTS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Dong Wha Pharma Co Ltd (000020):企業の財務・戦略的SWOT分析
    Summary Dong Wha Pharma Co Ltd (Dongwha Pharm) is a pharmaceutical company that offers generic products. The company offers ethical drugs, over-the-counter products, cosmetics, health foods, medical devices, and food and drinks. Its products comprise clzapine tablets, valaboom, aripico tablets, intr …
  • Nitto Denko Corporation:企業の戦略・SWOT・財務分析
    Nitto Denko Corporation - Strategy, SWOT and Corporate Finance Report Summary Nitto Denko Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Saneca Pharmaceuticals as:製薬・医療:M&Aディール及び事業提携情報
    Summary Saneca Pharmaceuticals as (Saneca Pharma) is a contract development and manufacturing organization that develops and manufactures active pharmaceutical ingredients and finished dosage forms. The organization provides products such as API's; 2-aminotridecane adipate, atorvastatin calcium crys …
  • Sidi Kerir Petrochemicals Co (SKPC):企業の財務・戦略的SWOT分析
    Summary Sidi Kerir Petrochemicals Co (Sidpec), a subsidiary of Egyptian Petrochemicals Holding Co, is a chemical company that manufactures and distributes petrochemical products. The company offers high density polyethylene and linear low density polyethylene which are used in plastic applications. …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆